The dataset provides data on suspected side-effects also known as suspected adverse drug reactions for authorised medicines in the European Economic Area (EEA).
For centrally authorised medicines, access to reports is granted both by the name of the medicine or the name of the active substance. For non-centrally authorised medicines, access is granted based on the name of the active substance only.
Build on reliable and scalable technology
FAQ
Frequently Asked Questions
Some basic informations about API Store ®.
Operation and development of APIs are currently fully funded by company Apitalks and its usage is for free.
Yes, you can.
All important information such as time of last update, license and other information are in response of each API call.
In case of major update that would not be compatible with previous version of API, we keep for 30 days both versions so you will have enough time to transfer to new version. We will inform you about the changes in advance by e-mail.